Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery

2017 ◽  
Vol 31 (5) ◽  
pp. 1857-1864 ◽  
Author(s):  
Michael Essandoh ◽  
Adam A. Dalia ◽  
Mazen Albaghdadi ◽  
Barry George ◽  
Nicoleta Stoicea ◽  
...  
Keyword(s):  
Antiplatelet Therapy ◽  
Perioperative Management ◽  
Dual Antiplatelet Therapy ◽  
Noncardiac Surgery ◽  
Metallic Stents ◽  
Vascular Scaffolds ◽  
Drug Eluting ◽  
Bioresorbable Vascular Scaffolds ◽  
New Generation

Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2

2015 ◽  
Vol 68 (10) ◽  
pp. 838-845 ◽  
Author(s):  
José M. de la Torre Hernández ◽  
Juan F. Oteo Domínguez ◽  
Felipe Hernández ◽  
Tamara García Camarero ◽  
Omar Abdul-Jawad Altisent ◽  
...  
Keyword(s):  
Antiplatelet Therapy ◽  
Stent Implantation ◽  
Dual Antiplatelet Therapy ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
New Generation

scholarly journals TCT-140 Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study.

2013 ◽  
Vol 62 (18) ◽  
pp. B45
Author(s):  
Jose M. De la Torre Hernandez ◽  
Juan F. Oteo Dominguez ◽  
Felipe Hernandez ◽  
Omar Abdul-Jawad Altisent ◽  
Fernando Rivero-Crespo ◽  
...  
Keyword(s):  
Antiplatelet Therapy ◽  
Stent Implantation ◽  
Dual Antiplatelet Therapy ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
New Generation ◽  
Multicenter Registry
Sign in / Sign up

Export Citation Format

Share Document